Podcast: Beyond Wearables--Profusa CEO Discusses Novel Tiny Injectable Biosensor For Long-Term Monitoring
Executive Summary
In this podcast interview with Medtech Insight, Profusa Inc. Chairman and CEO Ben Hwang discusses the company's long-term biochemical monitoring platform, the first application for its tiny injectable biosensor, and what's next for the company.
You may also be interested in...
Profusa Raised $45M To Market PAD-Monitoring Implant In Europe
Digital Health company Profusa raised more than $45m in a series C financing round. The company plans to use the proceeds to bring its tiny CE-marked injectable biosensors, used to monitor tissue oxygenation in patients with peripheral artery disease, to key opinion leaders and clinicians in Europe.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.